Singapore Facts & Figures Snapshot

The Big Picture

Singapore F&F_15


Singapore’s real GDP per person has grown incredibly since independence in 1965, helping the country make the leap from third world to first world in less than half a century.

Singapore F&F_05


Switzerland is the world’s leading nation for investor friendliness in terms of ease of doing business, labour force, and innovation input.

Singapore F&F_01


Singapore is home to over 40 percent of global MNCs’ regional headquarters.

Singapore F&F_17


Health Profile

The healthcare landscape in Singapore is rapidly changing, with an aging population necessitating a dramatic increase in demand for healthcare workers.

Singapore F&F_02


Asia is aging rapidly. This demographic shift will have profound consequences on healthcare dynamics throughout the region.

SINGAPORE_GRAPH_01


The Top 10 causes of death per year in Singapore: coronary heart disease and influenza and pneumonia are the most prevalent.

Singapore F&F_04


Singapore is by far the most developed and efficient healthcare provider in ASEAN and annually spends the most per capita on health.

Singapore F&F_03


Health risk factors in Singapore: smoking, alcohol consumption, and obesity.

Singapore F&F_16


Pharmaceutical Industry

Manufacturing as a percentage of GDP remains high in Singapore, especially compared to fellow Asian Tiger Hong Kong which has divested most of its manufacturing capabilities.

Singapore F&F_09


Biomedicals and chemicals make up a significant section of Singapore’s manufacturing output.

Singapore F&F_10


Generics penetration in Singapore is low compared to its regional neighbours.

Singapore F&F_11


Singapore’s export sector has gradually reduced in volume since the turn of the millennium, but pharmaceuticals could represent an opportunity to help revive it.

Singapore F&F_08

Clinical trials in Singapore in international comparison.

Singapore F&F_12


BioSciences

Singapore’s biomedical sciences industry spreads across the island, with a number of key hubs clustering together many of the APAC headquarters for major pharma and biotech MNCs.

SINGAPORE_GRAPH_03

 


Singapore has surged to fifth position in Scientific American’s global biotech rankings and also fares well in terms of R&D intensity, number of researchers per million people, and bioscience patent applications.

SINGAPORE_GRAPH_02

Similar Facts and Figures

Latest Reports